To the Editor:

Expression of the Tumor Suppressor Gene W1 in Both Human and Mouse Bone Marrow
The Wilms' Tumor gene ( W T I ) encodes a protein that functions as a zinc-finger transcription factor and represses transcription from the promoters of many growth factor and growth factor receptor genes."! W T I is thought to play a role in hematopoiesis and has been shown to repress the promoters of several genes expressed in hematopoietic cells (ie, CSF-I, RARcr, .'"This suggests that WTI may function as a transcriptional repressor of genes that control proliferation and/or differentiation in hematopoiesis. Two recent reports of low WTI expression in unfractionated human bone L M B N K M W 493 f 369
Fig 1. W 1 expression in human BM. Ethidium bromide stained 1.5% low melting agarose gel of RT-PCR-amplified products obtained from human hematopoietic cells. RNA was extracted and cDNA synthesized and amplified as described previ~usly,"'~'~ except that the cDNA was synthesized at 37°C and the PCR annealling temperature was 64°C. L, AML(M2) patient blood sample; M, normal CD34' BM; B, normal peripheral blood; N. No RNA; K, K562 cells; and MW, the 123-bp size markers. The p-actin (540 bp) and W1 (480 bp) PCR products are indicated. Leukemic cells and CD34* BM expressed significant levels of W 1 mRNA, but mature blood cells did not. marrow (BM) suggested that WTI may be expressed in a minor cell component. such as pluripotent hematopoietic stem cells, or that the cells expressing WTI do so only transiently.'." We tested these alternatives by examining CD34'FACS-sorted BM precursor cells' and found evidence of high levels of WTI expression. We also report here the first description of WTI expression in murine BM.
To measure the expression of WTI during normal hematopoiesis, we quantitated W T I mRNA levels (relative to P-actin mRNA) in a duplex primed reverse transcriptase-polymerase chain reaction (RT-PCR) assay, as described previously." The number of amplification cycles and cDNA concentrations used were titrated for maximal The kidney, spleen, and liver expressed high levels of WT1, whereas unfractionated BM, blood, yolk sac, and ES cells expressed low levels.
WTI amplification. The zinc-finger region (exons 7 to 10) was amplified by PCR as a 480-bp human cDNA and a 330-bp mouse cDNA. The 8-actin primers amplified a 540-bp product in both human and murine samples, but the WTI primers used were species specific.
[cy"P]-dCTP-labeled RT-PCR amplified human and mouse products were separated on a 1.5% low melting point agarose gel or 4% polyacrylamide gels, respectively. Gels were dried, analyzed using a phospho-imager (Molecular Dynamics, Sunnyvale, CA), and the ratios of [a"P]-dCTP-labeled RT-PCR-amplified WTI and Dactin products were averaged. We found that, although WTI was strongly expressed in immature CD34' BM stem cells, it was only weakly expressed in normal mature blood cells (Fig I) . We plan to identify the subpopulation of cells within the CD34' BM that expresses WTI, because CD34' BM cells contain progenitors of all lineages except T-lymphoid cells." In Table I , the ratios of human WTIIB-actin products were averaged for the number of samples tested (2 each for K562 and CD34-BM, 9 for normal blood, and 63 for AML). K562 cells, which were derived from a patient with chronic myelogenous leukemia in blast crisis. expressed the highest levels of WTI; BM and a blood sample from a patient with M2 acute myelogenous leukemia (AML) also expressed high levels. These data support the hypothesis that WTI is expressed in immature human hematopoietic cells, in both normal CD34' BM stem cells and immature leukemic cells, but not in mature human hematopoietic cells, eg, normal blood cells, or chronic phase leukemias?,"," ' We began the analysis of murine hematopoietic WTI expression by examining embryonic tissues. Hematopoiesis in the mouse occurs initially in the yolk sac with blood islands forming at 7 days post coitum (dpc) and active hematopoiesis beginning in the liver, spleen, and BM at 9 dpc." The liver is the principal hematopoietic organ from I2 to I6 dpc, and some hematopoietic foci are present at birth. The spleen and BM become the major fetal hematopoietic organs at 15 and 16 dpc, respectively." We observed WTI transcripts in the embryonic liver and yolk sac at 12.5 dpc; expression was higher in liver than in yolk sac (Fig 2) . Our findings suggest that WTI is expressed in the primary hematopoietic organ during definitive hematopoiesis. We have not examined earlier staged yolk sac to determine whether WTI is also expressed during primitive hematopoiesis. In Table I , the ratios of murine WTl/p-actin [d'PI-dCTPlabeled RT-PCR-amplified products were averaged from three experiments. Although liver and spleen expressed significant levels of WTI. we cannot rule out the possibility that WTI was expressed in the mesothelial lining" of these tissues; therefore, quantitation of WTI expression in these hematopoietic cells is problematic. However. the low-level expression of WTI in the adult BM and blood indicates hematopoietic expression in these tissues. We have not examined FACS-sorted murine BM, but, based on the human results, we predict strong WTI expression in murine pluripotent hematopoietic stem cells and a greater difference between blood and BM expression, as observed for human samples. The cultured ES cells (derived from 3.5 dpc blastocysts of mouse line 129) expressed WTI at levels comparable to the yolk-sac levels, but this may reflect culture conditions rather than bona fide early embryonic expression.
Our results support the findings of lnoue et alh and suggest that WTI may be useful clinically as a marker for minimal residual disease because mature blood cells lacked significant WTI expression and immature BM cells expressed high levels of WTI. The evidence indicating the functional relevance of WTI expression in hematopoietic cells includes ( I ) the presence of WTI mRNA in developing spleen and normal BM5.'."; (2) the inverse relation of WTI expression to the differentiation state of both normal and leukemic (3) the rapid downregulation of WTI expression in hematopoietic cell lines induced to differentiate","; and (4) the identification of mutations in the zinc-finger region of the WTI gene in some AML patients.'.'' For these reasons, we believe that WTI plays a significant role in hematopoiesis and hypothesize that WTI is involved in lineage selection by repression of a gene or genes required for differentiation of a specific hematopoietic lineage or lineages. 
